Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Fetal Monitoring Market

ID: MRFR/HC/20368-HCR
128 Pages
Nidhi Mandole
Last Updated: April 06, 2026

Fetal Monitoring Market Research Report: Size, Share, Trend Analysis By Product [Ultrasound Devices, Electronic Maternal/Fetal Monitors, Uterine Contraction Monitor (2D Ultrasound, 3D/4D Ultrasound, and Doppler Imaging) Fetal Electrodes, Fetal Doppler Devices, Telemetry Devices, Accessories and Consumables, and Other Products], By Portability (Portable systems, and Non-portable systems), By Method (Invasive, and Non-Invasive), By Applications (Antepartum, and Intrapartum), By End Users (Hospitals, Obstetrics and Gynecology Clinics, and Home Care Settings), And By Region –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Fetal Monitoring Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Product (USD Billion)
  49.     4.1.1 Ultrasound Devices
  50.     4.1.2 Electronic Maternal/Fetal Monitors
  51.     4.1.3 Uterine Contraction Monitor
  52.     4.1.4 Fetal Electrodes
  53.     4.1.5 Fetal Doppler Devices
  54.     4.1.6 Telemetry Devices
  55.     4.1.7 Accessories and Consumables
  56.     4.1.8 Others
  57.   4.2 Healthcare, BY Portability (USD Billion)
  58.     4.2.1 Portable systems
  59.     4.2.2 Non-portable systems
  60.   4.3 Healthcare, BY Method (USD Billion)
  61.     4.3.1 Invasive
  62.     4.3.2 Non-Invasive
  63.   4.4 Healthcare, BY Application (USD Billion)
  64.     4.4.1 Antepartum
  65.     4.4.2 Intrapartum
  66.   4.5 Healthcare, BY End User (USD Billion)
  67.     4.5.1 Hospitals
  68.     4.5.2 Obstetrics and Gynecology Clinics
  69.     4.5.3 Home Care Settings
  70.   4.6 Healthcare, BY Region (USD Billion)
  71.     4.6.1 North America
  72.       4.6.1.1 US
  73.       4.6.1.2 Canada
  74.     4.6.2 Europe
  75.       4.6.2.1 Germany
  76.       4.6.2.2 UK
  77.       4.6.2.3 France
  78.       4.6.2.4 Russia
  79.       4.6.2.5 Italy
  80.       4.6.2.6 Spain
  81.       4.6.2.7 Rest of Europe
  82.     4.6.3 APAC
  83.       4.6.3.1 China
  84.       4.6.3.2 India
  85.       4.6.3.3 Japan
  86.       4.6.3.4 South Korea
  87.       4.6.3.5 Malaysia
  88.       4.6.3.6 Thailand
  89.       4.6.3.7 Indonesia
  90.       4.6.3.8 Rest of APAC
  91.     4.6.4 South America
  92.       4.6.4.1 Brazil
  93.       4.6.4.2 Mexico
  94.       4.6.4.3 Argentina
  95.       4.6.4.4 Rest of South America
  96.     4.6.5 MEA
  97.       4.6.5.1 GCC Countries
  98.       4.6.5.2 South Africa
  99.       4.6.5.3 Rest of MEA
  100. 5 SECTION V: COMPETITIVE ANALYSIS
  101.   5.1 Competitive Landscape
  102.     5.1.1 Overview
  103.     5.1.2 Competitive Analysis
  104.     5.1.3 Market share Analysis
  105.     5.1.4 Major Growth Strategy in the Healthcare
  106.     5.1.5 Competitive Benchmarking
  107.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  108.     5.1.7 Key developments and growth strategies
  109.       5.1.7.1 New Product Launch/Service Deployment
  110.       5.1.7.2 Merger & Acquisitions
  111.       5.1.7.3 Joint Ventures
  112.     5.1.8 Major Players Financial Matrix
  113.       5.1.8.1 Sales and Operating Income
  114.       5.1.8.2 Major Players R&D Expenditure. 2023
  115.   5.2 Company Profiles
  116.     5.2.1 GE Healthcare (US)
  117.       5.2.1.1 Financial Overview
  118.       5.2.1.2 Products Offered
  119.       5.2.1.3 Key Developments
  120.       5.2.1.4 SWOT Analysis
  121.       5.2.1.5 Key Strategies
  122.     5.2.2 Philips Healthcare (NL)
  123.       5.2.2.1 Financial Overview
  124.       5.2.2.2 Products Offered
  125.       5.2.2.3 Key Developments
  126.       5.2.2.4 SWOT Analysis
  127.       5.2.2.5 Key Strategies
  128.     5.2.3 Siemens Healthineers (DE)
  129.       5.2.3.1 Financial Overview
  130.       5.2.3.2 Products Offered
  131.       5.2.3.3 Key Developments
  132.       5.2.3.4 SWOT Analysis
  133.       5.2.3.5 Key Strategies
  134.     5.2.4 Medtronic (US)
  135.       5.2.4.1 Financial Overview
  136.       5.2.4.2 Products Offered
  137.       5.2.4.3 Key Developments
  138.       5.2.4.4 SWOT Analysis
  139.       5.2.4.5 Key Strategies
  140.     5.2.5 Fujifilm Holdings Corporation (JP)
  141.       5.2.5.1 Financial Overview
  142.       5.2.5.2 Products Offered
  143.       5.2.5.3 Key Developments
  144.       5.2.5.4 SWOT Analysis
  145.       5.2.5.5 Key Strategies
  146.     5.2.6 Natus Medical Incorporated (US)
  147.       5.2.6.1 Financial Overview
  148.       5.2.6.2 Products Offered
  149.       5.2.6.3 Key Developments
  150.       5.2.6.4 SWOT Analysis
  151.       5.2.6.5 Key Strategies
  152.     5.2.7 Neoventa Medical AB (SE)
  153.       5.2.7.1 Financial Overview
  154.       5.2.7.2 Products Offered
  155.       5.2.7.3 Key Developments
  156.       5.2.7.4 SWOT Analysis
  157.       5.2.7.5 Key Strategies
  158.     5.2.8 Hologic, Inc. (US)
  159.       5.2.8.1 Financial Overview
  160.       5.2.8.2 Products Offered
  161.       5.2.8.3 Key Developments
  162.       5.2.8.4 SWOT Analysis
  163.       5.2.8.5 Key Strategies
  164.     5.2.9 Cardiotocography (CTG) (US)
  165.       5.2.9.1 Financial Overview
  166.       5.2.9.2 Products Offered
  167.       5.2.9.3 Key Developments
  168.       5.2.9.4 SWOT Analysis
  169.       5.2.9.5 Key Strategies
  170.   5.3 Appendix
  171.     5.3.1 References
  172.     5.3.2 Related Reports
  173. 6 LIST OF FIGURES
  174.   6.1 MARKET SYNOPSIS
  175.   6.2 NORTH AMERICA MARKET ANALYSIS
  176.   6.3 US MARKET ANALYSIS BY PRODUCT
  177.   6.4 US MARKET ANALYSIS BY PORTABILITY
  178.   6.5 US MARKET ANALYSIS BY METHOD
  179.   6.6 US MARKET ANALYSIS BY APPLICATION
  180.   6.7 US MARKET ANALYSIS BY END USER
  181.   6.8 CANADA MARKET ANALYSIS BY PRODUCT
  182.   6.9 CANADA MARKET ANALYSIS BY PORTABILITY
  183.   6.10 CANADA MARKET ANALYSIS BY METHOD
  184.   6.11 CANADA MARKET ANALYSIS BY APPLICATION
  185.   6.12 CANADA MARKET ANALYSIS BY END USER
  186.   6.13 EUROPE MARKET ANALYSIS
  187.   6.14 GERMANY MARKET ANALYSIS BY PRODUCT
  188.   6.15 GERMANY MARKET ANALYSIS BY PORTABILITY
  189.   6.16 GERMANY MARKET ANALYSIS BY METHOD
  190.   6.17 GERMANY MARKET ANALYSIS BY APPLICATION
  191.   6.18 GERMANY MARKET ANALYSIS BY END USER
  192.   6.19 UK MARKET ANALYSIS BY PRODUCT
  193.   6.20 UK MARKET ANALYSIS BY PORTABILITY
  194.   6.21 UK MARKET ANALYSIS BY METHOD
  195.   6.22 UK MARKET ANALYSIS BY APPLICATION
  196.   6.23 UK MARKET ANALYSIS BY END USER
  197.   6.24 FRANCE MARKET ANALYSIS BY PRODUCT
  198.   6.25 FRANCE MARKET ANALYSIS BY PORTABILITY
  199.   6.26 FRANCE MARKET ANALYSIS BY METHOD
  200.   6.27 FRANCE MARKET ANALYSIS BY APPLICATION
  201.   6.28 FRANCE MARKET ANALYSIS BY END USER
  202.   6.29 RUSSIA MARKET ANALYSIS BY PRODUCT
  203.   6.30 RUSSIA MARKET ANALYSIS BY PORTABILITY
  204.   6.31 RUSSIA MARKET ANALYSIS BY METHOD
  205.   6.32 RUSSIA MARKET ANALYSIS BY APPLICATION
  206.   6.33 RUSSIA MARKET ANALYSIS BY END USER
  207.   6.34 ITALY MARKET ANALYSIS BY PRODUCT
  208.   6.35 ITALY MARKET ANALYSIS BY PORTABILITY
  209.   6.36 ITALY MARKET ANALYSIS BY METHOD
  210.   6.37 ITALY MARKET ANALYSIS BY APPLICATION
  211.   6.38 ITALY MARKET ANALYSIS BY END USER
  212.   6.39 SPAIN MARKET ANALYSIS BY PRODUCT
  213.   6.40 SPAIN MARKET ANALYSIS BY PORTABILITY
  214.   6.41 SPAIN MARKET ANALYSIS BY METHOD
  215.   6.42 SPAIN MARKET ANALYSIS BY APPLICATION
  216.   6.43 SPAIN MARKET ANALYSIS BY END USER
  217.   6.44 REST OF EUROPE MARKET ANALYSIS BY PRODUCT
  218.   6.45 REST OF EUROPE MARKET ANALYSIS BY PORTABILITY
  219.   6.46 REST OF EUROPE MARKET ANALYSIS BY METHOD
  220.   6.47 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  221.   6.48 REST OF EUROPE MARKET ANALYSIS BY END USER
  222.   6.49 APAC MARKET ANALYSIS
  223.   6.50 CHINA MARKET ANALYSIS BY PRODUCT
  224.   6.51 CHINA MARKET ANALYSIS BY PORTABILITY
  225.   6.52 CHINA MARKET ANALYSIS BY METHOD
  226.   6.53 CHINA MARKET ANALYSIS BY APPLICATION
  227.   6.54 CHINA MARKET ANALYSIS BY END USER
  228.   6.55 INDIA MARKET ANALYSIS BY PRODUCT
  229.   6.56 INDIA MARKET ANALYSIS BY PORTABILITY
  230.   6.57 INDIA MARKET ANALYSIS BY METHOD
  231.   6.58 INDIA MARKET ANALYSIS BY APPLICATION
  232.   6.59 INDIA MARKET ANALYSIS BY END USER
  233.   6.60 JAPAN MARKET ANALYSIS BY PRODUCT
  234.   6.61 JAPAN MARKET ANALYSIS BY PORTABILITY
  235.   6.62 JAPAN MARKET ANALYSIS BY METHOD
  236.   6.63 JAPAN MARKET ANALYSIS BY APPLICATION
  237.   6.64 JAPAN MARKET ANALYSIS BY END USER
  238.   6.65 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
  239.   6.66 SOUTH KOREA MARKET ANALYSIS BY PORTABILITY
  240.   6.67 SOUTH KOREA MARKET ANALYSIS BY METHOD
  241.   6.68 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  242.   6.69 SOUTH KOREA MARKET ANALYSIS BY END USER
  243.   6.70 MALAYSIA MARKET ANALYSIS BY PRODUCT
  244.   6.71 MALAYSIA MARKET ANALYSIS BY PORTABILITY
  245.   6.72 MALAYSIA MARKET ANALYSIS BY METHOD
  246.   6.73 MALAYSIA MARKET ANALYSIS BY APPLICATION
  247.   6.74 MALAYSIA MARKET ANALYSIS BY END USER
  248.   6.75 THAILAND MARKET ANALYSIS BY PRODUCT
  249.   6.76 THAILAND MARKET ANALYSIS BY PORTABILITY
  250.   6.77 THAILAND MARKET ANALYSIS BY METHOD
  251.   6.78 THAILAND MARKET ANALYSIS BY APPLICATION
  252.   6.79 THAILAND MARKET ANALYSIS BY END USER
  253.   6.80 INDONESIA MARKET ANALYSIS BY PRODUCT
  254.   6.81 INDONESIA MARKET ANALYSIS BY PORTABILITY
  255.   6.82 INDONESIA MARKET ANALYSIS BY METHOD
  256.   6.83 INDONESIA MARKET ANALYSIS BY APPLICATION
  257.   6.84 INDONESIA MARKET ANALYSIS BY END USER
  258.   6.85 REST OF APAC MARKET ANALYSIS BY PRODUCT
  259.   6.86 REST OF APAC MARKET ANALYSIS BY PORTABILITY
  260.   6.87 REST OF APAC MARKET ANALYSIS BY METHOD
  261.   6.88 REST OF APAC MARKET ANALYSIS BY APPLICATION
  262.   6.89 REST OF APAC MARKET ANALYSIS BY END USER
  263.   6.90 SOUTH AMERICA MARKET ANALYSIS
  264.   6.91 BRAZIL MARKET ANALYSIS BY PRODUCT
  265.   6.92 BRAZIL MARKET ANALYSIS BY PORTABILITY
  266.   6.93 BRAZIL MARKET ANALYSIS BY METHOD
  267.   6.94 BRAZIL MARKET ANALYSIS BY APPLICATION
  268.   6.95 BRAZIL MARKET ANALYSIS BY END USER
  269.   6.96 MEXICO MARKET ANALYSIS BY PRODUCT
  270.   6.97 MEXICO MARKET ANALYSIS BY PORTABILITY
  271.   6.98 MEXICO MARKET ANALYSIS BY METHOD
  272.   6.99 MEXICO MARKET ANALYSIS BY APPLICATION
  273.   6.100 MEXICO MARKET ANALYSIS BY END USER
  274.   6.101 ARGENTINA MARKET ANALYSIS BY PRODUCT
  275.   6.102 ARGENTINA MARKET ANALYSIS BY PORTABILITY
  276.   6.103 ARGENTINA MARKET ANALYSIS BY METHOD
  277.   6.104 ARGENTINA MARKET ANALYSIS BY APPLICATION
  278.   6.105 ARGENTINA MARKET ANALYSIS BY END USER
  279.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
  280.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY PORTABILITY
  281.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY METHOD
  282.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  283.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  284.   6.111 MEA MARKET ANALYSIS
  285.   6.112 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT
  286.   6.113 GCC COUNTRIES MARKET ANALYSIS BY PORTABILITY
  287.   6.114 GCC COUNTRIES MARKET ANALYSIS BY METHOD
  288.   6.115 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  289.   6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER
  290.   6.117 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT
  291.   6.118 SOUTH AFRICA MARKET ANALYSIS BY PORTABILITY
  292.   6.119 SOUTH AFRICA MARKET ANALYSIS BY METHOD
  293.   6.120 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  294.   6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER
  295.   6.122 REST OF MEA MARKET ANALYSIS BY PRODUCT
  296.   6.123 REST OF MEA MARKET ANALYSIS BY PORTABILITY
  297.   6.124 REST OF MEA MARKET ANALYSIS BY METHOD
  298.   6.125 REST OF MEA MARKET ANALYSIS BY APPLICATION
  299.   6.126 REST OF MEA MARKET ANALYSIS BY END USER
  300.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  301.   6.128 RESEARCH PROCESS OF MRFR
  302.   6.129 DRO ANALYSIS OF HEALTHCARE
  303.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  304.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  305.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  306.   6.133 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
  307.   6.134 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion)
  308.   6.135 HEALTHCARE, BY PORTABILITY, 2024 (% SHARE)
  309.   6.136 HEALTHCARE, BY PORTABILITY, 2024 TO 2035 (USD Billion)
  310.   6.137 HEALTHCARE, BY METHOD, 2024 (% SHARE)
  311.   6.138 HEALTHCARE, BY METHOD, 2024 TO 2035 (USD Billion)
  312.   6.139 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  313.   6.140 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  314.   6.141 HEALTHCARE, BY END USER, 2024 (% SHARE)
  315.   6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  316.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  317. 7 LIST OF TABLES
  318.   7.1 LIST OF ASSUMPTIONS
  319.     7.1.1
  320.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  321.     7.2.1 BY PRODUCT, 2025-2035 (USD Billion)
  322.     7.2.2 BY PORTABILITY, 2025-2035 (USD Billion)
  323.     7.2.3 BY METHOD, 2025-2035 (USD Billion)
  324.     7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
  325.     7.2.5 BY END USER, 2025-2035 (USD Billion)
  326.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  327.     7.3.1 BY PRODUCT, 2025-2035 (USD Billion)
  328.     7.3.2 BY PORTABILITY, 2025-2035 (USD Billion)
  329.     7.3.3 BY METHOD, 2025-2035 (USD Billion)
  330.     7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
  331.     7.3.5 BY END USER, 2025-2035 (USD Billion)
  332.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  333.     7.4.1 BY PRODUCT, 2025-2035 (USD Billion)
  334.     7.4.2 BY PORTABILITY, 2025-2035 (USD Billion)
  335.     7.4.3 BY METHOD, 2025-2035 (USD Billion)
  336.     7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
  337.     7.4.5 BY END USER, 2025-2035 (USD Billion)
  338.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  339.     7.5.1 BY PRODUCT, 2025-2035 (USD Billion)
  340.     7.5.2 BY PORTABILITY, 2025-2035 (USD Billion)
  341.     7.5.3 BY METHOD, 2025-2035 (USD Billion)
  342.     7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
  343.     7.5.5 BY END USER, 2025-2035 (USD Billion)
  344.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  345.     7.6.1 BY PRODUCT, 2025-2035 (USD Billion)
  346.     7.6.2 BY PORTABILITY, 2025-2035 (USD Billion)
  347.     7.6.3 BY METHOD, 2025-2035 (USD Billion)
  348.     7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
  349.     7.6.5 BY END USER, 2025-2035 (USD Billion)
  350.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  351.     7.7.1 BY PRODUCT, 2025-2035 (USD Billion)
  352.     7.7.2 BY PORTABILITY, 2025-2035 (USD Billion)
  353.     7.7.3 BY METHOD, 2025-2035 (USD Billion)
  354.     7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
  355.     7.7.5 BY END USER, 2025-2035 (USD Billion)
  356.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  357.     7.8.1 BY PRODUCT, 2025-2035 (USD Billion)
  358.     7.8.2 BY PORTABILITY, 2025-2035 (USD Billion)
  359.     7.8.3 BY METHOD, 2025-2035 (USD Billion)
  360.     7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
  361.     7.8.5 BY END USER, 2025-2035 (USD Billion)
  362.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  363.     7.9.1 BY PRODUCT, 2025-2035 (USD Billion)
  364.     7.9.2 BY PORTABILITY, 2025-2035 (USD Billion)
  365.     7.9.3 BY METHOD, 2025-2035 (USD Billion)
  366.     7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
  367.     7.9.5 BY END USER, 2025-2035 (USD Billion)
  368.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  369.     7.10.1 BY PRODUCT, 2025-2035 (USD Billion)
  370.     7.10.2 BY PORTABILITY, 2025-2035 (USD Billion)
  371.     7.10.3 BY METHOD, 2025-2035 (USD Billion)
  372.     7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
  373.     7.10.5 BY END USER, 2025-2035 (USD Billion)
  374.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  375.     7.11.1 BY PRODUCT, 2025-2035 (USD Billion)
  376.     7.11.2 BY PORTABILITY, 2025-2035 (USD Billion)
  377.     7.11.3 BY METHOD, 2025-2035 (USD Billion)
  378.     7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
  379.     7.11.5 BY END USER, 2025-2035 (USD Billion)
  380.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  381.     7.12.1 BY PRODUCT, 2025-2035 (USD Billion)
  382.     7.12.2 BY PORTABILITY, 2025-2035 (USD Billion)
  383.     7.12.3 BY METHOD, 2025-2035 (USD Billion)
  384.     7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
  385.     7.12.5 BY END USER, 2025-2035 (USD Billion)
  386.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  387.     7.13.1 BY PRODUCT, 2025-2035 (USD Billion)
  388.     7.13.2 BY PORTABILITY, 2025-2035 (USD Billion)
  389.     7.13.3 BY METHOD, 2025-2035 (USD Billion)
  390.     7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
  391.     7.13.5 BY END USER, 2025-2035 (USD Billion)
  392.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  393.     7.14.1 BY PRODUCT, 2025-2035 (USD Billion)
  394.     7.14.2 BY PORTABILITY, 2025-2035 (USD Billion)
  395.     7.14.3 BY METHOD, 2025-2035 (USD Billion)
  396.     7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
  397.     7.14.5 BY END USER, 2025-2035 (USD Billion)
  398.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  399.     7.15.1 BY PRODUCT, 2025-2035 (USD Billion)
  400.     7.15.2 BY PORTABILITY, 2025-2035 (USD Billion)
  401.     7.15.3 BY METHOD, 2025-2035 (USD Billion)
  402.     7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
  403.     7.15.5 BY END USER, 2025-2035 (USD Billion)
  404.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  405.     7.16.1 BY PRODUCT, 2025-2035 (USD Billion)
  406.     7.16.2 BY PORTABILITY, 2025-2035 (USD Billion)
  407.     7.16.3 BY METHOD, 2025-2035 (USD Billion)
  408.     7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
  409.     7.16.5 BY END USER, 2025-2035 (USD Billion)
  410.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  411.     7.17.1 BY PRODUCT, 2025-2035 (USD Billion)
  412.     7.17.2 BY PORTABILITY, 2025-2035 (USD Billion)
  413.     7.17.3 BY METHOD, 2025-2035 (USD Billion)
  414.     7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
  415.     7.17.5 BY END USER, 2025-2035 (USD Billion)
  416.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  417.     7.18.1 BY PRODUCT, 2025-2035 (USD Billion)
  418.     7.18.2 BY PORTABILITY, 2025-2035 (USD Billion)
  419.     7.18.3 BY METHOD, 2025-2035 (USD Billion)
  420.     7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
  421.     7.18.5 BY END USER, 2025-2035 (USD Billion)
  422.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  423.     7.19.1 BY PRODUCT, 2025-2035 (USD Billion)
  424.     7.19.2 BY PORTABILITY, 2025-2035 (USD Billion)
  425.     7.19.3 BY METHOD, 2025-2035 (USD Billion)
  426.     7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
  427.     7.19.5 BY END USER, 2025-2035 (USD Billion)
  428.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  429.     7.20.1 BY PRODUCT, 2025-2035 (USD Billion)
  430.     7.20.2 BY PORTABILITY, 2025-2035 (USD Billion)
  431.     7.20.3 BY METHOD, 2025-2035 (USD Billion)
  432.     7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
  433.     7.20.5 BY END USER, 2025-2035 (USD Billion)
  434.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  435.     7.21.1 BY PRODUCT, 2025-2035 (USD Billion)
  436.     7.21.2 BY PORTABILITY, 2025-2035 (USD Billion)
  437.     7.21.3 BY METHOD, 2025-2035 (USD Billion)
  438.     7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
  439.     7.21.5 BY END USER, 2025-2035 (USD Billion)
  440.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  441.     7.22.1 BY PRODUCT, 2025-2035 (USD Billion)
  442.     7.22.2 BY PORTABILITY, 2025-2035 (USD Billion)
  443.     7.22.3 BY METHOD, 2025-2035 (USD Billion)
  444.     7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
  445.     7.22.5 BY END USER, 2025-2035 (USD Billion)
  446.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  447.     7.23.1 BY PRODUCT, 2025-2035 (USD Billion)
  448.     7.23.2 BY PORTABILITY, 2025-2035 (USD Billion)
  449.     7.23.3 BY METHOD, 2025-2035 (USD Billion)
  450.     7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
  451.     7.23.5 BY END USER, 2025-2035 (USD Billion)
  452.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  453.     7.24.1 BY PRODUCT, 2025-2035 (USD Billion)
  454.     7.24.2 BY PORTABILITY, 2025-2035 (USD Billion)
  455.     7.24.3 BY METHOD, 2025-2035 (USD Billion)
  456.     7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
  457.     7.24.5 BY END USER, 2025-2035 (USD Billion)
  458.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  459.     7.25.1 BY PRODUCT, 2025-2035 (USD Billion)
  460.     7.25.2 BY PORTABILITY, 2025-2035 (USD Billion)
  461.     7.25.3 BY METHOD, 2025-2035 (USD Billion)
  462.     7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
  463.     7.25.5 BY END USER, 2025-2035 (USD Billion)
  464.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  465.     7.26.1 BY PRODUCT, 2025-2035 (USD Billion)
  466.     7.26.2 BY PORTABILITY, 2025-2035 (USD Billion)
  467.     7.26.3 BY METHOD, 2025-2035 (USD Billion)
  468.     7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
  469.     7.26.5 BY END USER, 2025-2035 (USD Billion)
  470.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  471.     7.27.1 BY PRODUCT, 2025-2035 (USD Billion)
  472.     7.27.2 BY PORTABILITY, 2025-2035 (USD Billion)
  473.     7.27.3 BY METHOD, 2025-2035 (USD Billion)
  474.     7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
  475.     7.27.5 BY END USER, 2025-2035 (USD Billion)
  476.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  477.     7.28.1 BY PRODUCT, 2025-2035 (USD Billion)
  478.     7.28.2 BY PORTABILITY, 2025-2035 (USD Billion)
  479.     7.28.3 BY METHOD, 2025-2035 (USD Billion)
  480.     7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
  481.     7.28.5 BY END USER, 2025-2035 (USD Billion)
  482.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  483.     7.29.1 BY PRODUCT, 2025-2035 (USD Billion)
  484.     7.29.2 BY PORTABILITY, 2025-2035 (USD Billion)
  485.     7.29.3 BY METHOD, 2025-2035 (USD Billion)
  486.     7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
  487.     7.29.5 BY END USER, 2025-2035 (USD Billion)
  488.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  489.     7.30.1 BY PRODUCT, 2025-2035 (USD Billion)
  490.     7.30.2 BY PORTABILITY, 2025-2035 (USD Billion)
  491.     7.30.3 BY METHOD, 2025-2035 (USD Billion)
  492.     7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
  493.     7.30.5 BY END USER, 2025-2035 (USD Billion)
  494.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  495.     7.31.1
  496.   7.32 ACQUISITION/PARTNERSHIP
  497.     7.32.1

Healthcare Market Segmentation

Healthcare By Product (USD Billion, 2025-2035)

  • Ultrasound Devices
  • Electronic Maternal/Fetal Monitors
  • Uterine Contraction Monitor
  • Fetal Electrodes
  • Fetal Doppler Devices
  • Telemetry Devices
  • Accessories and Consumables
  • Others

Healthcare By Portability (USD Billion, 2025-2035)

  • Portable systems
  • Non-portable systems

Healthcare By Method (USD Billion, 2025-2035)

  • Invasive
  • Non-Invasive

Healthcare By Application (USD Billion, 2025-2035)

  • Antepartum
  • Intrapartum

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Obstetrics and Gynecology Clinics
  • Home Care Settings

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions